Objective: We wanted to evaluate the status of self-expandable nitinol stents implanted in the P2 and P3 segments of the popliteal artery in Korean patients. Materials and Methods: We retrospectively analyzed 189 consecutive patients who underwent endovascular treatment for stenoocclusive lesions in the femoropopliteal artery from July 2003 to March 2009, and 18 patients who underwent stent placement in popliteal arterial P2 and P3 segments were fi nally enrolled. Lesion patency was evaluated by ultrasound or CT angiography, and stent fracture was assessed by plain X-rays at 1, 3, 6 and 12 months and annually thereafter. Results: At the 1-month follow-up, stent fracture (Type 2) was seen in one limb (up to P3, 1 of 18, 6%) and it was identifi ed in seven limbs at the 3-month follow-up (Type 2, Type 3, Type 4) (n = 1: up to P2; n = 6: P3). At the 6-month follow-up, one more fracture (Type 1) (up to P3) was noted. At the 1-year follow-up, there were no additional stent fractures. Just four limbs (up to P2) at the 2-year follow-up did not have stent fracture. The primary patency was 94%, 61% and 44% at 1, 3 and 6 months, respectively, and the group with stent implantation up to P3 had a higher fracture rate than that of the group that underwent stenting up to P2 (p < 0.05).
INTRODUCTION
The technical and clinical success rates of endovascular
The Primary Patency and Fracture Rates of SelfExpandable Nitinol Stents Placed in the Popliteal Arteries, Especially in the P2 and P3 Segments, in Korean Patients treatment for stenoocclusive lesions in the femoropopliteal artery have reached over 90% due to the improvements in the new generation devices (1, 2) . However, the long-term patency of endovascular treatment remains an unsolved issue. In particular, balloon angioplasty alone and stainlesssteel stent placement in the femoropopliteal artery have been far from satisfactory, and their primary patencies over 1-year follow-up are below 60% (3) (4) (5) (6) . New nitinol stents have recently been introduced and these have been proven to be superior to balloon angioplasty (7, 8) or a stainlesssteel stent (9) in the superfi cial femoral artery in terms of the long-term patency. Therefore, endovascular treatment with nitinol stents has been widely applied for treating femoropopliteal stenoocclusive lesions. However, despite the improved primary patency, stent fracture after the deployment of nitinol stents has been recognized as an adverse event in the femoropopliteal artery and this can be considered as a risk factor for in-stent restenosis and reocclusion in a femoropopliteal arterial stent. Although the factors that have an infl uence on femoropopliteal arterial stent fracture have not been fully determined, stent fracture is believed to occur due to external compression caused by muscle activity, by pulsatile blood fl ow that seems to negatively affect the stent structures, by overlapping long stents or by mechanical stress at the articulation sites (7, (10) (11) (12) (13) . In particular, popliteal arterial segments P2 and P3 were previously avoided for stent placement due to the articulation sites where a stent could easily be bent (13, 14) . Yet in practice, it is inevitable that a stent is placed in the popliteal arterial segments P2 and P3 in the case of critical limb ischemia or for bail-out after balloon angioplasty. Unfortunately, there has been little data regarding the status of stents placed in the popliteal arterial segments P2 and P3 and especially in Asian patients who often fi nd it necessary to fully fl ex the knee joints in order to perform routine activities such as kneeling, squatting and sitting with both legs crossed. Therefore, the purpose of this study is to evaluate the primary patency and morphological status of self-expandable nitinol stents in the popliteal arteries, and especially the P2 and P3 segments, in Korean patients. Patency and Fracture Rates of Popliteal-Artery Self-Expandable Nitinol Stents in Terms of Their Locations (P2 vs. P3) out of the 189 patients who underwent endovascular treatment for femoropopliteal stenoocclusive lesions and who had lesions that included the popliteal arterial P2 and P3 segments. Twenty-nine limbs had stenosis, 13 limbs had an occlusion and 10 limbs had a mixed lesion of both stenosis and occlusion. All the endovascular treatments were performed in the interventional procedure room. Written informed consent was obtained from all the study subjects and this retrospective study was approved by the Institutional Review Board of our institution. Standardized heparin 3000-5000 IU was administered systematically via the introducer sheath at the beginning of the intervention. The indication for endovascular treatment for femoropopliteal lesions included > 70% of vessel diameter stenosis without infl ow lesions after obtaining the initial diagnostic angiograms of the lower limb. The approaches for endovascular treatment for the femoropopliteal lesions were determined at the operator's discretion. In general, after inserting a 6-Fr or 7-Fr sheath, either a 0.035-or a 0.018-inch guide wire supported by a differently shaped diagnostic catheter was used to cross the lesion. The modalities for endovascular treatment were as follows: Primary stent placement was performed for the stenoocclusive lesion in the SFA and the P1 segment of the popliteal artery. Balloon angioplasty or primary stent placement was performed in the popliteal arterial P2 and P3 segments and bail-out stenting was performed in the patients with unsuccessful primary balloon angioplasty, which was defi ned as a residual stenosis > 30% or the presence of a fl ow-limiting dissection. Balloon catheters or stents between 5 to 8 mm were used depending on the target lesion. A variety of balloon catheters (UT: Boston Scientifi c, Natick, MA; Powerfl ex: Cordis, Miami, FL; Rider: Bolton, Barcelona, Spain) and a single selfexpandable nitinol stent (SMART: Cordis, Miami, FL) were used. Dual antiplatelet therapy with aspirin (100 mg/day) and clopidogrel (75 mg/day) was started immediately after the procedure and this was continued until the 1-month follow-up for clopidogrel and the duration of treatment was life-long for aspirin.
MATERIALS AND METHODS
Stent fracture was defi ned as clear interruption of the stent struts as identifi ed by plain X-rays from at least two projections, with resulting kink or misalignment along the axial length of the stent. The morphology of the stent fracture was classifi ed based on a report by Rocha-Singh et al. (15) . Single-strut fracture was defi ned as type 1, multiple-strut fractures was defi ned as type 2, stent fracture with preserved alignment of the components fractures was defi ned as type 3, stent fracture with mal-alignment of the components fractures was defi ned as type 4 and stent fracture in a trans-axial spiral confi guration fractures was defi ned as type 5. Lesion patency was evaluated by ultrasound or CT angiography, and stent fracture was assessed by X-rays at 1, 3, 6 and 12 months and annually thereafter.
Endovascular procedures were considered technically successful when all the treated lesions had < 20% residual stenosis on completion of angiography. Primary patency was defi ned as the absence of restenosis or occlusion in the treated arterial segment. Restenosis was defi ned as more than 50% of the vessel diameter at the treated segments as observed on CT angiography or the absence of fl ow or a focal increase of the peak systolic velocity ratio of ≥ 2.5 on color Duplex ultrasound. Additionally, lesion patency according to the type of stent fracture was analyzed, and the difference in stent fracture according to stent implantation until P2 or until P3 and over P2 was also analyzed.
Statistical analysis was performed using SPSS. The Chisquare test was used to compare the fractures between the groups with stent implantation until P2 and until P3 over P2, P2 with the level of statistical signifi cance set at p values < 0.05. Primary patency was determined by performing Kaplan-Meier survival analysis.
RESULTS
Technical success was achieved in 100% of the patients who underwent stent placement in the popliteal arterial P2 or P3 segments (lesion length: 8-27 cm, mean lesion length: 16.5 cm). Forty-one of 52 limbs underwent balloon angioplasty to recanalize the stenoocclusive lesions and among them, seven limbs underwent stent placement in the popliteal arterial P2 and P3 segments for bail-out because of inappropriate results of balloon angioplasty such as elastic recoil (n = 1) or fl ow-limiting dissection (n = 6). Of them, two limbs underwent bail-out stent placement at up to the P2 segment and fi ve limbs underwent bailout stent placement at up to the P3 segment and over the P2 segment. The remaining eleven of 52 limbs underwent primary stenting in the popliteal arterial P2 and P3 segments due to severe calcifi cation or critical limb ischemia. Eight limbs underwent stent placement up to the P2 segment and 3 limbs underwent stent placement up to Il Soo Chang et al. the P3 and over the P2 segment.
At the 1-month follow-up, stent fracture (Type 2) was seen in one limb that underwent primary stenting up to the popliteal arterial P3 segment and over the P2 segment (1 of 18, 6%); stent fracture was identifi ed in seven limbs at 3-month follow-up (Type 1, Type 2, Type 3 and multiple; n = 1, n = 4, n = 1 and n = 1, respectively), including one of 10 limbs that underwent stent placement up to the P2 segment (Type 1) (Fig. 1) and six limbs that underwent stent placement up to the P3 and over the P2 segment (Type 2, Type 3 and multiple) (Figs. 2, 3 ). At the 6-month followup, one more fracture (Type 2) was noted in a residual limb that underwent stent placement up to the P3 segment. Therefore, all the limbs (n = 8) that underwent stent placement up to the popliteal arterial P3 segment had a stent fracture at the 6-month follow-up and just one limb (1 of 10, 10%) had a fracture in the stent placed up to the P2 segment. At the 1-year follow-up there was no additional stent fracture in the 12 limbs that were available for followup. Just four limbs were available for the 2-year follow-up; each of them had undergone stent placement up to the P2 segment and none had developed new stent fracture.
A total of nine limbs experienced overt stent fracture during the follow-up period; among them, type 2 fractures were identifi ed in six limbs, type 1 fracture was identifi ed in one limb and type 3 fracture was identifi ed in one limb. One limb had a multiple-type of fracture such as combined type 2, type 3 and type 4. The blood fl ow through the stent was completely occluded at the time of detection of stent fracture in all the cases of type 2, 3 and 4 fractures, but the stent patency was well preserved in the case of type 1 fracture. In addition, all the cases that underwent stent placement up to the popliteal arterial P3 segment and over the P2 segment demonstrated stent fractures with complete occlusion of blood fl ow; however, the cases that underwent stent placement up to the P2 segment included just one case of stent fracture without evidence of stenosis or occlusion. Therefore, the group with stent implantation up to the P3 segment had a higher fracture rate than did the group that was stented up to the P2 segment (p < 0.05). The overall primary patency was 94%, 61% and 44% at 1, 3 and 6 months, respectively (Table 1) .
There were no peri-procedural complications and all of the patients were discharged within seven days of their procedure.
DISCUSSION
Endovascular intervention in the peripheral circulation has proven to be problematic. Although generally effective in the relatively large infl ow arteries of the extracranial cerebrovascular and iliac circulations, endovascular manipulation of the infrainguinal arteries is technically more challenging and the outcome less durable (7, (16) (17) (18) (19) (20) . There are many possible explanations for the discouraging results of infrainguinal endovascular intervention. The infrainguinal circulation is characterized by long conduits with a heavy plaque burden, high impedance outfl ow with low mean fl ow rates, prolonged fractions of the cardiac cycle with stagnant fl ow and a tendency toward exaggerated bending and twisting with skeletal movement (21) . The latter phenomenon contributes to stent fracture of self-expanding stents in the femoropopliteal arteries. Indeed, self-expanding stents in the SFA have shown an alarming tendency to fracture, with rates as high as 65% in one clinical report (22) ; another recent clinical study of 40 consecutive patients treated with the Luminexx stent documented strut fracture in 28%, with more frequent occurrence in the patients who were vigorously active and ambulatory (23) . There have been many studies of stent patency and stent fracture in the femoropopliteal arteries. In our study, stent fracture worsened the patency during the fi rst two years, but it did not apparently affect the patency beyond two years. Although type 2 stent fracture revealed poor outcomes, neither type 1 nor type 3 stent fractures affected the primary patency compared with those stents without stent fracture (7, 8) . In our study, all the cases with type 2 stent fractures had complete occlusion of blood fl ow, while good stent patency was identifi ed with type 1 stent fracture; these results were similar to those of previous studies. However, contrary to the previous studies, the cases of type 3 stent fracture in our study had complete occlusion of stent patency, although one case had a mixed lesion that included type 2 and type 4 fractures. Therefore, this study cannot give us a full answer regarding the correlation between stent patency and the types of stent fracture because of the small number of type 3 stent fractures (n = 2) and the small total number of cases with stent fracture (n = 9).
In general, stent implantation in the femoropopliteal arteries has been performed in the SFA and proximal popliteal artery (P1 segment), and one study recommended that stent implantation be avoided in the middle or distal third of the popliteal artery (the P2 and P3 segments) (13) . While those previous studies observed stent fracture in the femoropopliteal arteries, they did not analyze the stent status in the bending portion of the popliteal arterial P2 and P3 segments. In addition, although it is well known that stent implantation in the popliteal arterial P2 and P3 Fig. 3 . 87-year-old man had diabetes with resting pain in his right foot. He had chronic total occlusion from mid-superfi cial femoral artery to popliteal arterial P3 segment with massive calcifi cations (arrowheads). Therefore, he underwent primary stenting there. However, at 3-month follow-up, his symptoms had recurred and type 2, 3 and 4 fractures (arrows) were detected on fl uoroscopy. segments can be considered harmful, it is very diffi cult to fi nd results regarding the stent structural problems such as fracture after implantation in the popliteal arterial P2 and P3 segments. Although our study involved a small study population, it will be valuable to analyze the stent status in the popliteal arterial P2 and P3 segments, which are more vulnerable to mechanical forces such as bending than are the SFA and the popliteal arterial P1 segment.
Iida et al. (24) suggested in their study that the incidence of stent fracture was lower than that observed in the FESTO (Femoral Stenting in Obstructions) trial (12) , and this result may be attributed to the differences of the life-styles and physique in the Eastern population. They assumed that the body mass index in the patients included in that study was approximately 22 kg/m 2 and it may be interesting to speculate that stent fracture is adversely affected by muscle volume through compression and expansion mechanisms. However, that study did not mention the stent status in the middle or distal popliteal artery. Full fl exion is often necessary in Asian culture to perform key routine activities such as kneeling, squatting and sitting with both legs crossed; in response to such demand, efforts have been made to achieve greater fl exion of stents in the knee joint of the Asian population than that in the Western population. Therefore, we assumed that stent placement in the popliteal arterial P2 and P3 segments in the Asian population may result in more structural problems of stents, such as fracture, than that in the Western population and in fact, all of our patients who underwent stent placement over P2 and up to the P3 segment of the popliteal artery had stent fracture accompanied by complete occlusion. Our study has some limitations and shortcomings. First, this study was retrospectively conducted. Second, the number of cases was few and the follow-up data over six months was incomplete. Third, our study did not collect data regarding re-intervention in the case of stent fracture with complete occlusion of blood fl ow because all the patients refused the second intervention and some of them moved to other hospitals. Fourth, only one type of stent was used during the period of this study; therefore, it may be diffi cult to apply our results to other stents. Fifth, our study did not analyze the clinical symptomatic improvement after technically successful stent placement due to the lack of medical records regarding this.
In conclusion, we suggest that self-expandable stent placement up to the popliteal arterial P3 segment and over the P2 segment can worsen the preservation of stent patency with a high incidence of stent fracture, and especially in the Korean population. It is necessary to develop a stent design and structure that can resist the bending force in the knee joint.
